Biotechnology

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV(R) trial for chronic Hepatitis B at the EASL International Liver Congress(TM)

June 25, 2022
GlobeNewsWire

PRESS RELEASE

The post Immunocore announces the presentation of initial data from the Phase 1 ImmTAV(R) trial for chronic Hepatitis B at the EASL International Liver Congress(TM) appeared first on Bio Tech Winners.

Read MoreBio Tech Winners